INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹276 Cr | ₹103 Cr | ₹55 Cr | ₹53 Cr | ₹25 Cr |
What is the latest Capital Work in Progress ratio of INDOCO REMEDIES ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹276 Cr |
| Mar2024 | ₹103 Cr |
| Mar2023 | ₹55 Cr |
| Mar2022 | ₹53 Cr |
| Mar2021 | ₹25 Cr |
How is Capital Work in Progress of INDOCO REMEDIES Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹276 Cr | 168.41 | |
| Mar2024 | ₹103 Cr | 85.71 | |
| Mar2023 | ₹55 Cr | 4.88 | |
| Mar2022 | ₹53 Cr | 110.26 | |
| Mar2021 | ₹25 Cr | - | |
Compare Capital Work in Progress of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,056.9 Cr | 2.7% | -7.5% | -29.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -2.6% | 2.4% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹221,666.0 Cr | 6.5% | 23.3% | 25.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,108.0 Cr | 2.6% | 3% | 33.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.1% | -0.2% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,990.9 Cr | 2.6% | -13.3% | -10.7% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 2.7% |
-7.5% |
-29.8% |
| SENSEX | 1.2% |
0.4% |
-2.9% |
You may also like the below Video Courses